The Claim
A proportional reduction in major vascular events of 1.0 mmol/L LDL cholesterol lowering is similar across all cardiovascular risk categories, including individuals with less than 5% and 5–10% 5-year risk.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Lowering LDL cholesterol by 1.0 mmol/L reduces the risk of major vascular events by a similar amount in people with low, moderate, and high risk of cardiovascular disease.
See the scientific wording
The proportional reduction in major vascular events per 1.0 mmol/L LDL reduction is similar across all risk categories, including those with <5% and 5–10% 5-year risk, indicating that benefit is not limited to high-risk individuals.
Lowering LDL cholesterol stops more fatty material from building up inside artery walls, which makes existing plaques less likely to rupture and trigger blood clots that cause heart attacks and strokes.
What the research says
1 studyStatins lower LDL cholesterol and reduce heart attacks and strokes by about the same percentage in people with very low risk as in those with high risk — meaning even people with low risk can benefit significantly from statins.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.